chrisvoncsefalvay/vaers-outcomes huggingface dataset:
red blood cell count is very low; This is a spontaneous report from a contactable female consumer (patient) reported for herself. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number and expiration date was not reported), via an unspecified route of administration on 17Mar2021 as dose 1, single for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported as red blood cell count is very low on an unspecified date in Mar2021. It was reported that, patient received her 1st dose on 17Mar2021 and due to have her 2nd dose on 07Apr2021. She was taking Prednisone after the 1st dose because her red blood cell count was very low. Patient enquired if she should put off her 2nd dose or she could continue taking her 2nd dose and medication at the same time. The patient underwent lab tests and procedures which included red blood cell count: low on an unspecified date. The patient received treatment with prednisone after the 1st dose because her red blood cell count is very low. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Pt received first dose Pfizer and apx 5 minutes after vaccination stated in observation that he was lightheaded, dizzy and had blurry vision. Pt's vitals: 81/56, pulse ox 100%, HR 67, lungs clear bilater, pt diaphoretic and clammy, pale. States feels like is passing out. EMS called. Pt did not lose consciousness at any point. BP repeat 104/61 prior to EMS arrival. Pt given water and soda. EMS blood sugar 121, evaluated patient, pt states feeling better and declines to go to hospital. Pt's color improved. Pt stayed in observation until 2:25 with stated improvement in all symptoms. Vitals when patient left: BP 116/75, HR 60, pulse ox: 100%, no signs and symptoms of distress. Pt educated to call 911 or go to nearest hospital if symptoms return, verbalized understanding.
I was 28 weeks and 5 days pregnant when I received the first dose of the COVID19 vaccine.  Two days later (12/25/2020 in the afternoon), I noticed decreased motion of the baby.   The baby was found to not have a heartbeat in the early am on 12/26/2020 and I delivered a 2lb 7oz nonviable female fetus at 29 weeks gestation.   I was 35 years old at the time of the fetal demise and the only pregnancy history for this pregnancy included a velamentous cord insertion that was being closely monitored by a high risk OB.   My estimated due was March 12, 2021.
First Moderna vaccine received 7/8/2021  Patient reports first episode of irregular/unscheduled vaginal/uterine bleeding started 7/11/2021 Patient is virginal with a history of regular periods  States the bleeding was heavy, as of today patient is still bleeding
Super itchy body rash all over body. Hives/urticaria. Ongoing  for 5 days at point of filing this report(still ongoing). Swollen wrists, knees and ankles. Joint pain in fingers, wrists, knees and ankles.  Still ongoing. Prescribed allergy meds.
Had mammogram 3 months prior to vaccine showing "No suspicious masses, calcifications, or other findings in either breast."  Discovered two palpable left breast masses (same laterality as vaccine administration) 5.5 weeks later.  Breast MRI performed, followed by ultrasound with biopsies of a total of THREE lesions.  1. Left breast 22mm x 14mm x 23mm mass, posterior 11:00 (diagnosis by biopsy = fibroadenoma), 2. Left breast 14mm x 12mm x 8mm mass, 12:00 (diagnosis by biopsy = cellular fibroadenoma), 3. Right breast 8mm x 5mm x 6mm mass, retroareolar (diagnosis by biopsy = fibroadenoma).  No prior diagnosis of fibroadenoma and three tumors after vaccination.  Follow-up mammogram 9 months post vaccine shows all three lesions are now visible on mammography (they were not on mammogram 3 months prior to vaccine) with similar sizes (left breast 11:00 posterior lesion currently measures 21mm x 14mm x 24mm, previously was 22mm x 14mm x 23mm; left breast 12:00 lesion measures 14mm x 7mm x 15mm, previously was 14mm x 12mm x 8mm; right breast lesion 8 mm oval hypoechoic lesion, previously was 8mm x 5mm x 6mm).
discomfort in arm; This is a spontaneous report from a contactable consumer (Patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for Covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced discomfort in arm for a couple of days on an unspecified date. Outcome of event was unknown.   Information about lot/batch number has been requested.
After 1st dose of Pfizer:  Nausea, and trouble breathing (Oxygen went up and down from 90 to 95) - Took to Dr and advise to watch oxygen levels After 2nd dose of Pfizer:  Nausea, Dry heaves, Stomach Pain, Head Aches, Back Pain, Loosing Control of Bladder (Kidney Failure), Trouble Breathing (Oxygen went under 90) - Took to her Dr and she said to take her to the Emergency Room due to her Oxygen going below 90. I took her to Hospital.
Recurrence of redness of skin surrounding the injection site, increased swelling, recurrence of itching, and slight tenderness. This all occurred after all soreness, pain and redness was all resolved. The injection site was slightly swollen but had gone down significantly since the first 24 hours of the injection.
About 1 month after receiving the J&J Covid vaccine patient noticed numbness/tingling in the smaller 3 fingers of his right hand. Around the same time, he noticed weakness in his right hand also.  He received his vaccine in his left deltoid.
fever, vomiting,malise, headache could not get out of bed for 2 weeks after 1st shot.  Developed periphreal neurapathy within 30 days of 1st shot.  However it took 3 months to diagnose. Gastritis several times. Migraines constantly, fainting with muscle weakness...can not use legs for hours after faintinf, bloody stools, paralysis in right arm immediately after third vaccine.  Pallor, clamminess, amennorhea no period since first vaccine.  fatigue, insomnia, sleep apnea, chest pain, pins and needle sensations throughout extremities, sinusitis several times, pins and needles feelings in stomach, fevers on and off, slurred speech.  She has been very ill since first vaccine and in a lot of pain.  5/1/09 Received vaccine & PCP medical records of 11/14/06-1/9/2009. FINAL DX: none provided Records reveal patient experienced shooting paine & numbness of extremities 2 wks prior to HPV #1 & flu shot. RTC w/recurrent depression, left plantar fasciitis, migraine HAs.  Seen in ER 3/13/08 for HA & dx w/ethmoid sinusitis, tonsillitis & URI.  RTC w/viral gastroenteritis, right CTS, recurrent allergic rhinitis.  8/18/08 w/spells x 3-4 yrs which had increased in frequency x 3 wks; dx w/presyncopal episodes.  Seen in ER w/dx gastroenteritis.  Referred to Neuro for syncope.  Missed several days of school.  RTC for LBP s/p fall, gastritis w/bloody stools.  6/15/09 Received consultant medical records of 1/29/08-5/26/2009. Pulmonology records reveal patient experienced sleep disturbance, obstructive sleep apnea, increasing obesity, nasal congestion, and allergic rhinitis. Residual cough. Low bloodpressure. ENT - intranasal mucosal edema and clear drainage, deviated septum, mouth and oral cavity small, enlarged tonsils, redundant pharyngeal mucosa, obese neck. Tonsillectomy / Adenoidectomy. Neurology -  patient c/o burning in feet, dizzeness, fainting spells, clamminess, sweating, shooting pains in wrists /ankles, difficulty focusing / concentrating. Examination is unremarkable. Ophthalmologic evaluation reports some loss of peripheral vision.
pt recv vax 12MAR96 & 22MAR96 pt devel a fever of 102 & the following day pt broke out in about 3 dozen lesions on scalp, trunk & extremities;pt seen in ER & dx w/varicella & pneumonia;tx med;CXR revealed atelectasis or an alveolar
Headache, nausea, mod/severe severe body aches, insomnia - 24 hours
This spontaneous report was received from a medical assistant, referring to a  multiple unspecified patients of unknown ages and genders. The patients' pertinent medical history, concurrent conditions and concomitant medications were not provided. On an unknown date, the patients were vaccinated with and incorrect stored dose of PROQUAD lot # N014947 with expiration date on 11-SEP-2018 (strength and route were not reported) for prophylaxis, however no adverse effects reported. Other suspect therapies included sterile diluent (STERILE DILUENT). It was reported that the vaccines were exposed to temperature of 30 Farenheit grades range for a time frame of 4 hours and 40 minutes. The temperature excursion was recorded by a data logger and no previous excursions were reported for the vaccines. There was no product quality complaint involved. This is one of the several reports received from the same reporter. ; Sender's Comments: US-009507513-1709USA005854:
This spontaneous report as received from a Pharmacy student refers to a female patient of unknown age. On 16-NOV-2013 the patient was vaccinated with an inadvertent low dose of ZOSTAVAX, VIAL, (lot #, expiration date, dose and route unspecified) as a result of needle leakage. No adverse effect reported. Additional information has been requested.
pain, redness & swelling <16hr p/vax in rt thigh;began tx w/keflex approx 20hr p/vax for dx of cellulitis @ inj site;low grade temp;exam on 8/19/99 10AM dec swelling & redness, + weight bearing;
Chicken pox #2 dose on 6/25/13 at depart of health. Pt started having itching, swelling with hives at vaccine site on (L) arm. Went to ER on 6/27/13. Given antibiotics. S/S improved. Started having itching, redness, swelling again on 6/29/13.
Information has been received from a registered nurse concerning a 43 month old female with a multicystic dysplastic right kidney and recurrent otitis media, and with no known drug allergies who on 30JUN2001 (reported as 31JUN2001) was vaccinated SC in the right arm with a first dose of varicella virus vaccine live. There was no illness at the time of vaccination. It was also reported that the pt was also vaccinated IM in the right arm with a third dose of hepatitis b virus vaccine rHBsAg+ Hib conj vaccine on 28JUN2001. On 23JAN2004 the pt presented with chickenpox. At the time of the report, the child had not yet been seen by the physician but the diagnosis was made from information received over the phone. Unspecified medical attention was sought. There was no product quality complaint. Follow up information received from a registered nurse indicated that on 16JAN2004, the pt developed varicella pox after an "unvaccinated" sibling had varicella. the pt's pox spots rapidly spread to the entire body, including the inside of the mouth to the eyelids. Her eyelids were swollen shut. The pt also had a fever of 101-102 degrees. The pt continued to have a pox breakout that spread through 23JAN2004. The pox finally began to scab on 29JAN2004. The pt was treated with diphenhydramine hydrochloride, acetaminophen and oatmeal baths. the outcome was reported as recovered on 29JAN2004. No relevant diagnostic tests or laboratory data were reported. There were no adverse events following prior vaccination of the patient. The reporter also indicated that 2 of the patient's siblings developed mild varicella after vaccination with varicella virus vaccine live. This patient's case was worse than her siblings. No further information is expected.
This spontaneous prospective pregnancy report was received from a nurse via a company representative refers to a 33 year old female patient. The patient's medical history, concurrent condition and concomitant medications were unknown. On an unknown date, the patient was vaccinated with GARDASIL 9 (strength, dose, unit, frequency, route of administration, Lot/batch number and expiration date unknown) for prophylaxis. The nurse stated that the patient had completed the GARDASIL 9 series, 15 years ago. On an unknown date, the patient underwent Papanicolaou smear test that showed Human Papilloma Virus (HPV) positive pap and was diagnosed with Human Papilloma Virus (HPV) positive pap that had precancerous cells. The patient was told that she was pregnant. The Last Menstrual Period and Estimated Due Date was not known. The patient was rendered treatment for the events. On an unknown date, the patient underwent cone biopsy and the results were not reported. The pregnancy outcome was pending. The outcome of human papilloma virus test positive, exposure before pregnancy and precancerous cells present were unknown. The reporter 's causality assessment was not provided. The patient sought medical attention.
Arm soreness at injection site for 1.5 days following vaccine; fatigue within 4 hours of shot; severe HSV1 outbreak on upper lip began 2 days after shot
Initial unsolicited pregnancy report received from a nurse via phone on 11-Sep-2018. This case involves a 23 years old female patient who was exposed to vaccine ADACEL at 24 weeks and 1 day gestational age. The patient was exposed to DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE at 27 weeks of pregnancy, during third pregnancy trimester for DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE. The date of last menstrual period was reported as 07-Mar-2018. The estimated due date is 12-Dec-2018. The patient previous pregnancies was unknown. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. It is a case of vaccine exposure during pregnancy. Relevant prenatal testing after exposure included was unknown. Other relevant tests included no lab data. Additionally, at time of reporting, the pregnancy is still ongoing. List of documents held by sender: none.
This spontaneous report as received from registered nurse refers to a patient of unknown age and unknown gender. Patient's concurrent conditions and relevant medical history was not reported. On 16-SEP-2014 the patient was vaccinated with VAQTA, 0.5 ml, intramuscular; M-M-R II, 0.5 ml, subcutaneous and VARIVAX (Merck) 0.5 ml, subcutaneous. On 22-DEC-2014 the patient was vaccinated with VAQTA, 0.5 ml, intramuscular; M-M-R II, 0.5 ml, subcutaneous and VARIVAX (Merck) 0.5 ml, subcutaneus, and experienced inappropriate schedule of drug administration. No adverse effects (no adverse event) were reported. The outcome of the events was unknown. The causality of the events with suspect therapies was not reported. Additional information has been requested.
On 1/18/22 Pt seen in ER and found to be Covid-19 positive and discharged home on doxycyline for cellulitis. Pt reports developing blisters in LE after discharge. Pt returned for worsening cellulitis and blistering. While in the ER after receiving IV zosyn, she did develop several episodes of vomiting.  Venous duplex was obtained in the ER and was negative for DVT. Pt admitted for acute on chronic bilateral lower extremity bullous cellulitis with previous history of beta-hemolytic strep cellulitis.  Patient does have severe allergy to cephalosporin and has COVID-19 infection without hypoxia.   Patient was cleared for discharge by Infectious Disease.  Patient is being discharged home on January 25, 2022 in stable condition.
pt recvd vax 24FEB94 & devel intense itching, rash over abdo spreading to trunk, legs, arms & forehead on 26FEB94; also had 2 episodes of wheezing on 25FEB94; referred to own MD on 28FEB94 who treated employee w/Seldane & Pred;
10 min after injection hot flash, 1 hour p injection quarter size red welt, raised and hot to touch 24 hrs p injection dollar size red welt, raised size of goose egg and hot to touch.  Also, all joints ache. 48 hrs p injection same as above 24 hrs
chills, shivering, headache and feeling feverish for about 10 hours following vaccination.  also tingling/slight burning sensation at top of spine /  base of neck.
Fever, edema erythema tenderness at injection site, RX Ibuprofen 800mg, Medrol Dose Pak
Patient given injections in office on 3/6/03. Seen back in office on 3/7/03. Mom stated shortly after 2:00, redness and left thigh started. Indurated area, swollen, 13cmx9cm area. Very red and warm to touch around injection site. Child admitted for 3 days. Rechecked child after hospital discharge; seen on 3/14/03. Cellulitis cleared.
Patient developed a scarlatini form line rash after receiving five vaccines and eating gelatin almost simultaneously.  Rash occurred within 1 hour.
Headache; Sleepiness; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and SOMNOLENCE (Sleepiness) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No medical history information was reported.     On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced HEADACHE (Headache) and SOMNOLENCE (Sleepiness). At the time of the report, HEADACHE (Headache) and SOMNOLENCE (Sleepiness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  Patient received treatment including Tylenol 250 mg. Patient stated patient "took 1 pill to relief headache." This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 25-Jan-2021 and was forwarded to Moderna on 28-Jan-2021.    This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and SOMNOLENCE (Sleepiness) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No medical history information was reported.     On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced HEADACHE (Headache) and SOMNOLENCE (Sleepiness). At the time of the report, HEADACHE (Headache) and SOMNOLENCE (Sleepiness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  Patient received treatment including Tylenol 250 mg. Patient stated patient "took 1 pill to relief headache."
Pt recvd vax 11AUG92 & fainted, became diaphoretic & exp ringing in ears immed following vax; pt recovered the same day; no further details were provided;
Patient received an influenza vaccine and Pneumonia vaccine at the pharmacy. Pt reported that the day after her vaccine, her lip became swollen, her eyes became dry and "rashy" and she reported new tingling in her left nipple and vaginal area. Pt did not report vaccine side effects at the time that it happened. She is unsure if the reaction was to the influenza vaccine or the pneumonia vaccine. The lip swelling resolved on it's own after a day or so. Pt was seen by opthamology for eye irritation and was given an ointment to treat the rash and dryness in her eyes. She has not received any other doses of influenza vaccine or pneumonia vaccine since this incident 4 years ago. Pt reported reaction to myself (RN) today in clinic so I am filing the report.
received a dose of the Moderna COVID-19 Vaccine that expired on July 25th; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received a dose of the Moderna COVID-19 Vaccine that expired on July 25th) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (received a dose of the Moderna COVID-19 Vaccine that expired on July 25th). On 27-Jul-2021, EXPIRED PRODUCT ADMINISTERED (received a dose of the Moderna COVID-19 Vaccine that expired on July 25th) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   Treatment information was not provided.
Patient received first dose of Moderna COVID vaccine at 1136 today.  9 minutes after injection patient c/o feeling short of breath and that her throat was closing.   Began to have headache with humming in her ears.   1146- BP 176/92, HR 130s, O2 sats 100% on RA   1148-BP 154/89, HR 77, O2 sats 99% on RA with symptoms already resolving, only c/o mild headache at this time.  Patient never appeared to be short of breath   1152 BP- 143/88, HR 67, O2 sats remain wnl   1155- only complaint is feeling shaky and mild headache, no s/s of distress noted   1156- BP 142/84, HR 68, O2 sat 100% on RA, humming in ears now resolved   1203-transported to UC by RN
10/12/2022 I began to have symptoms that seemed like allergies and after a couple days, I started running a fever and tested COVID-19 positive on 14OCT2022. I had a sore throat, headaches, congestion. I was able to receive a prescription for PAXLOVID and cough medicine on Saturday. I was given the additional cough medicine which helped out a lot with the symptoms. I took many different medications like MUCINEX, homeopathic allergy relief as well. After taking the PAXLOVID, I started to already feel better that very evening. My fever broke and I never had a fever afterwards. I did however experience a disgusting mouth taste after every dose. As of now I am still experiencing fatigue, my taste is still off, and no other symptoms are present.
Patient stopped by the pharmacy at about  1130a.m. on 10/28/2023. Patient reported possible borderline anaphylactic shock at about 8:30 pm on 10/27/23, he was transported the emergency room via girlfriend. Patient had the flu vaccine at the pharmacy at about 6 PM on 10/27/23. Patient has had Flu vaccine his whole life without any problems. He ate Hamburger Helper, Ginger ale and frozen mix vegetables ( corn, peas, carrots and green beans).  Patient is allergic to peanuts and Penicillin. Patient was expressing swelling of throat and constant tickling. So he took benadryl 1 capsule and was transported to the emergency room. Once in ER, he was give benadryl, Epipen and steriod injection.
tiredness, injection site pain, headache, itchey, chills, nausea, feeling unwell, swelling of throat, slight rash
Noted 1 " from injection site redness, itching, no pain, fever x 3 days (103) after injection.  Dr. assessed pt in office on 8-20-10.
TC from pt one hour after recurring second shot of GARDASIL.  Pt self report "3 white spots, on my face" noticed after she left the clinic.  "a little itchy" advised to go to Urgent care- denied sob, facial swelling no other hives or itchiness.  Pt did not go to Urgent care she called her mom who told her to call her primary care doctor who advised her to take po BENADRYL which she did.  Attempt to call pt to see if symptoms resolved- pt did not call back yet.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 17-JUL-2015, the patient was vaccinated with an improperly stored dose of GARDASIL 0.5 ml (lot # K011492, expiration date 22-JUN-2016). No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time (hour), the lowest recorded temperature (Fahrenheit degree/Celsius) and the type of excursion (R/F) for each time were 24, 34 and R. The total cumulative excursion time (hour), the highest recorded temperature (Fahrenheit degree/Celsius) and the type of excursion (R/F) for each time were 176, 48 and R. The storage criteria was refrigerator (R). This is one of several reports received from the same source. Additional information has been requested.